世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域のセルライト治療市場予測 2023-2032

アジア太平洋地域のセルライト治療市場予測 2023-2032


ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST 2023-2032

主な調査結果 アジア太平洋地域のセルライト治療市場は、2023年から2032年の予測期間においてCAGR 9.78%で成長すると予測されています。この地域の市場成長には、治療費やプレミアム医療サービスの低価格化、高... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Inkwood Research
インクウッドリサーチ 		2023年3月4日 US$1,600
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		2-3営業日以内 164 英語

　

サマリー

主な調査結果
アジア太平洋地域のセルライト治療市場は、2023年から2032年の予測期間においてCAGR 9.78%で成長すると予測されています。この地域の市場成長には、治療費やプレミアム医療サービスの低価格化、高品質の医療施設だけでなく熟練した専門家の存在、美容施術の増加といった主要な要因が主に寄与しているものと思われます。
市場インサイト
アジア太平洋地域のセルライト治療市場の成長分析は、中国、韓国、タイ、インドネシア、ベトナム、日本、インド、オーストラリア＆ニュージーランド、およびその他のアジア太平洋地域の詳細な評価で構成されています。世界経済フォーラム（WEF）のデータによると、韓国の55歳以上の高齢者数は、2011年の1100万人から2020年には1670万人に増加しました。その後、老年人口が増加することにより、セルライト治療製品の需要が増加し、市場成長につながると考えられています。
一方、国際貿易局（ITA）によると、韓国は世界でも有数の美容市場であり、その革新性、快適なパッケージ、優しい成分で評価されています。また、韓国関税庁の統計によると、スキンケア化粧品は最大の輸入品目であり続け、2021年の化粧品輸入総額の34.17%に相当する。したがって、セルライト治療に対する意識の高まりは、韓国における美意識の高い個人の増加と相まって、予測期間中にアジア太平洋地域のセルライト治療市場全体の成長に貢献すると予想されます。
競合他社の洞察
市場で事業を展開している主要企業には、ジョンソン・エンド・ジョンソン、Nubway Co Ltd、AbbVie Incなどがあります。
当社のレポート提供内容は以下の通りです：
- 市場全体の主要な調査結果を探る
- 市場ダイナミクス（推進要因、抑制要因、機会、課題）の戦略的な内訳説明
- すべてのセグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
- 市場セグメンテーション：主要なセグメントを徹底的に評価し、その市場規模を推定します。
- 地域別分析：地域および国別セグメントの評価とその市場占有率
- 主要な分析ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要な購買基準など。
- 競合環境は、要因や市場シェアなどに基づいて主要企業を理論的に説明したものです。
- 企業プロファイリング：詳細な会社概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など。


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING BEAUTY CONSCIOUSNESS
2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
3.1.2. RISING CASES OF OBESITY
3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
3.2.2. SIDE EFFECTS POST-TREATMENT
3.2.3. LACK OF AWARENESS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT DEVELOPMENT
4.7.3. MARKETING AND DISTRIBUTION
4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. BRAND REPUTATION
4.8.3. USABILITY
5. MARKET BY PROCEDURE
5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL
6. MARKET BY TYPE
6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
8.1.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
8.1.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. CHINA
8.1.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.2. JAPAN
8.1.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.3. INDIA
8.1.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.4. SOUTH KOREA
8.1.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.5. THAILAND
8.1.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.6. INDONESIA
8.1.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.7. VIETNAM
8.1.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.8. AUSTRALIA & NEW ZEALAND
8.1.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.9. REST OF ASIA-PACIFIC
8.1.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. FINANCIAL ANALYSIS
9.2.1.3. PRODUCTS / SERVICES LIST
9.2.1.4. STRENGTHS & CHALLENGES
9.2.2. ALMA LASERS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS / SERVICES LIST
9.2.3. BAUSCH HEALTH COMPANIES INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. FINANCIAL ANALYSIS
9.2.3.3. PRODUCTS / SERVICES LIST
9.2.3.4. STRENGTHS & CHALLENGES
9.2.4. CANDELA CORPORATION
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS / SERVICES LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. CUTERA INC
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. FINANCIAL ANALYSIS
9.2.5.3. PRODUCTS / SERVICES LIST
9.2.5.4. STRENGTHS & CHALLENGES
9.2.6. CYNOSURE LLC
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS / SERVICES LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. ENDO INTERNATIONAL PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. FINANCIAL ANALYSIS
9.2.7.3. PRODUCTS / SERVICES LIST
9.2.7.4. STRENGTHS & CHALLENGES
9.2.8. GALDERMA SA
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS / SERVICES LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. INCELER MEDIKAL CO LTD
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS / SERVICES LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. JOHNSON & JOHNSON
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. FINANCIAL ANALYSIS
9.2.10.3. PRODUCTS / SERVICES LIST
9.2.10.4. STRENGTHS & CHALLENGES
9.2.11. MERZ PHARMA GMBH & CO KGAA
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS / SERVICES LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. NUBWAY CO LTD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS / SERVICES LIST
9.2.13. SIENTRA INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. FINANCIAL ANALYSIS
9.2.13.3. PRODUCTS / SERVICES LIST
9.2.13.4. STRENGTHS & CHALLENGES
9.2.14. SINCLAIR PHARMA
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS / SERVICES LIST
9.2.15. ZIMMER MEDIZINSYSTEME
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS / SERVICES LIST
9.2.15.3. STRENGTHS & CHALLENGES

ページTOPに戻る



図表リスト

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

　

ページTOPに戻る


　

Summary

KEY FINDINGS
The Asia-Pacific cellulite treatment market is predicted to grow with a CAGR of 9.78% over the forecasted years of 2023-2032. Key factors, such as the lower cost of treatments and premium healthcare services, the presence of skilled professionals as well as high quality healthcare facilities, and the increasing number of cosmetic procedures, are mainly accredited to the market growth of the region.
MARKET INSIGHTS
The Asia-Pacific cellulite treatment market growth analysis comprises a detailed assessment of China, South Korea, Thailand, Indonesia, Vietnam, Japan, India, Australia & New Zealand, and Rest of Asia-Pacific. As per the World Economic Forum (WEF) data, the number of individuals aged 55 years or above in South Korea increased to 16.7 million in 2020 from 11 million in 2011. Subsequently, the increasing geriatric populace is set to increase the demand for cellulite treatment products, thus leading to market growth.
On the other hand, according to the International Trade Administration (ITA), South Korea is one of the leading beauty markets globally, recognized for its innovation, pleasing packaging, and gentle ingredients. Aligning with this, as per the Korea Customs Service statistics, skincare cosmetics continued to be the greatest import category, equating to 34.17% of total cosmetic imports in the year 2021. Therefore, the rising awareness about cellulite treatment, coupled with the increasing number of aesthetic-conscious individuals in South Korea, is expected to contribute to the overall growth of the cellulite treatment market in the Asia-Pacific during the forecast years.
COMPETITIVE INSIGHTS
Some of the leading companies operating in the market are Johnson & Johnson, Nubway Co Ltd, AbbVie Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING BEAUTY CONSCIOUSNESS
2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
3.1.2. RISING CASES OF OBESITY
3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
3.2.2. SIDE EFFECTS POST-TREATMENT
3.2.3. LACK OF AWARENESS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT DEVELOPMENT
4.7.3. MARKETING AND DISTRIBUTION
4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. BRAND REPUTATION
4.8.3. USABILITY
5. MARKET BY PROCEDURE
5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL
6. MARKET BY TYPE
6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
8.1.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
8.1.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. CHINA
8.1.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.2. JAPAN
8.1.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.3. INDIA
8.1.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.4. SOUTH KOREA
8.1.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.5. THAILAND
8.1.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.6. INDONESIA
8.1.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.7. VIETNAM
8.1.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.8. AUSTRALIA & NEW ZEALAND
8.1.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.9. REST OF ASIA-PACIFIC
8.1.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. FINANCIAL ANALYSIS
9.2.1.3. PRODUCTS / SERVICES LIST
9.2.1.4. STRENGTHS & CHALLENGES
9.2.2. ALMA LASERS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS / SERVICES LIST
9.2.3. BAUSCH HEALTH COMPANIES INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. FINANCIAL ANALYSIS
9.2.3.3. PRODUCTS / SERVICES LIST
9.2.3.4. STRENGTHS & CHALLENGES
9.2.4. CANDELA CORPORATION
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS / SERVICES LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. CUTERA INC
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. FINANCIAL ANALYSIS
9.2.5.3. PRODUCTS / SERVICES LIST
9.2.5.4. STRENGTHS & CHALLENGES
9.2.6. CYNOSURE LLC
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS / SERVICES LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. ENDO INTERNATIONAL PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. FINANCIAL ANALYSIS
9.2.7.3. PRODUCTS / SERVICES LIST
9.2.7.4. STRENGTHS & CHALLENGES
9.2.8. GALDERMA SA
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS / SERVICES LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. INCELER MEDIKAL CO LTD
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS / SERVICES LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. JOHNSON & JOHNSON
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. FINANCIAL ANALYSIS
9.2.10.3. PRODUCTS / SERVICES LIST
9.2.10.4. STRENGTHS & CHALLENGES
9.2.11. MERZ PHARMA GMBH & CO KGAA
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS / SERVICES LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. NUBWAY CO LTD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS / SERVICES LIST
9.2.13. SIENTRA INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. FINANCIAL ANALYSIS
9.2.13.3. PRODUCTS / SERVICES LIST
9.2.13.4. STRENGTHS & CHALLENGES
9.2.14. SINCLAIR PHARMA
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS / SERVICES LIST
9.2.15. ZIMMER MEDIZINSYSTEME
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS / SERVICES LIST
9.2.15.3. STRENGTHS & CHALLENGES

ページTOPに戻る



List of Tables/Graphs

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Inkwood Research社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630